Literature DB >> 2570569

The beta-adrenergic radioligand [3H]CGP-12177, generally classified as an antagonist, is a thermogenic agonist in brown adipose tissue.

N Mohell1, A Dicker.   

Abstract

The effect of CGP-12177, originally developed as a radioligand with antagonist properties for binding studies of beta-adrenergic receptors, was investigated in brown adipose tissue. Contrary to expectations, CGP-12177 showed clear agonist properties in experiments with hamster brown-fat cells, with a maximal effect in stimulating oxygen consumption similar to that of the physiological stimulator noradrenaline, and also with a potency similar to that of noradrenaline [EC50 (50% effective concn.) approx. 70 nM]. This value could be contrasted with the very high affinity of CGP-12177 (KD about 1 nM) for ligand-binding sites on the cells. It is therefore suggested that the high-affinity binding site may not be the one that mediates the CGP-12177-stimulated thermogenesis in isolated cells. Also, when injected into cold-adapted rats, CGP-12177 stimulated non-shivering thermogenesis similarly to noradrenaline. This observation, in conjunction with the reported low general sympathomimetic effect of CGP-12177, may indicate that CGP-12177 could be of interest for the development of anti-obesity drugs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2570569      PMCID: PMC1138840          DOI: 10.1042/bj2610401

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Beta-Adrenergic receptors in brown-adipose tissue. Characterization and alterations during acclimation of rats to cold.

Authors:  L Bukowiecki; N Follea; J Vallieres; J Leblanc
Journal:  Eur J Biochem       Date:  1978-12-01

2.  The role of hormone receptors and GTP-regulatory proteins in membrane transduction.

Authors:  M Rodbell
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

Review 3.  The brown fat cell.

Authors:  J Nedergaard; O Lindberg
Journal:  Int Rev Cytol       Date:  1982

4.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

5.  High number of high-affinity binding sites for (-)-[3H]dihydroalprenolol on isolated hamster brown-fat cells. A study of the beta-adrenergic receptors.

Authors:  P Svoboda; J Svartengren; M Snochowski; J Houstĕk; B Cannon
Journal:  Eur J Biochem       Date:  1979-12

6.  Abnormal brown adipose composition and beta-adrenoceptor binding in obese Zucker rats.

Authors:  B E Levin; K Comai; R A O'Brien; A C Sullivan
Journal:  Am J Physiol       Date:  1982-09

7.  Interactions of some partial agonists with high and low affinity binding sites in beta-adrenoceptors.

Authors:  I Takayanagi; K Koike; A Nakagoshi
Journal:  Can J Physiol Pharmacol       Date:  1987-01       Impact factor: 2.273

8.  Impaired metabolic response to nerve stimulation in brown adipose tissue of hypothyroid rats.

Authors:  J Seydoux; J P Giacobino; L Girardier
Journal:  Mol Cell Endocrinol       Date:  1982-02       Impact factor: 4.102

9.  Alpha 1- and beta-adrenergic receptors in brown adipose tissue of lean (Fa/?) and obese (fa/fa) Zucker rats. Effects of cold-acclimation, sucrose feeding and adrenalectomy.

Authors:  A Raasmaja; D A York
Journal:  Biochem J       Date:  1988-02-01       Impact factor: 3.857

10.  A reliable assay for beta-adrenoceptors in intact isolated human fat cells with a hydrophilic radioligand, [3H]CGP-12177.

Authors:  D Lacasa; P Mauriège; M Lafontan; M Berlan; Y Giudicelli
Journal:  J Lipid Res       Date:  1986-04       Impact factor: 5.922

View more
  23 in total

Review 1.  Pharmacological approaches for the treatment of obesity.

Authors:  José-Antonio Fernández-López; Xavier Remesar; Màrius Foz; Marià Alemany
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Direct demonstration of beta1- and evidence against beta2- and beta3-adrenoceptors, in smooth muscle cells of rat small mesenteric arteries.

Authors:  Ana M Briones; Craig J Daly; Francesc Jimenez-Altayo; Sonia Martinez-Revelles; Jose M Gonzalez; John C McGrath; Elisabet Vila
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

3.  Adrenergic stimulation of lipoprotein lipase gene expression in rat brown adipocytes differentiated in culture: mediation via beta3- and alpha1-adrenergic receptors.

Authors:  P Kuusela; S Rehnmark; A Jacobsson; B Cannon; J Nedergaard
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

4.  β(3) Receptors: Role in Cardiometabolic Disorders.

Authors:  Shraddha V Bhadada; Bhoomika M Patel; Anita A Mehta; Ramesh K Goyal
Journal:  Ther Adv Endocrinol Metab       Date:  2011-04       Impact factor: 3.565

5.  Beta 1-, beta 2- and atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta.

Authors:  L Brawley; A M Shaw; A MacDonald
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

6.  Interaction of amiodarone and triiodothyronine on the expression of beta-adrenoceptors in brown adipose tissue of rat.

Authors:  H Adli; R Bazin; G Y Perret
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

7.  Pharmacological characterization of CGP 12177 at the human beta(2)-adrenoceptor.

Authors:  Jillian G Baker; Ian P Hall; Stephen J Hill
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

8.  In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue.

Authors:  P Barbe; L Millet; J Galitzky; M Lafontan; M Berlan
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

9.  Pharmacology and direct visualisation of BODIPY-TMR-CGP: a long-acting fluorescent beta2-adrenoceptor agonist.

Authors:  Jillian G Baker; Ian P Hall; Stephen J Hill
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

10.  ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.

Authors:  Nataraj Brahmadevara; Angus M Shaw; Allan MacDonald
Journal:  Br J Pharmacol       Date:  2004-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.